Iron Overdose: Deferoxamine Indications for MRCP Part 1

TL;DR:

Iron Overdose: Deferoxamine Indications is a frequently tested toxicology topic in MRCP Part 1, especially in questions involving metabolic acidosis, shock, or paediatric poisoning. Candidates should recognise the clinical stages of toxicity, know when deferoxamine is indicated, and avoid classic traps such as using activated charcoal. Understanding the timing of symptoms and the significance of systemic toxicity is essential for exam success.

Why Iron Overdose Matters in MRCP Part 1

Iron poisoning appears repeatedly in postgraduate examinations because it tests:

• Recognition of toxicological emergencies

• Interpretation of acid–base abnormalities

• Clinical prioritisation

• Knowledge of antidotes

• Awareness of delayed complications

The exam commonly focuses on:

• Clinical stages of poisoning

• Indications for deferoxamine

• Serum iron interpretation

• Radiographic findings

• Ineffectiveness of activated charcoal

• Hepatic complications

Unlike many overdoses, iron toxicity may initially appear to improve before severe systemic deterioration develops. This “latent phase” is a classic examination trap.

Pathophysiology of Iron Toxicity

Iron becomes toxic when transferrin-binding capacity is overwhelmed. Excess free iron generates oxidative injury and disrupts oxidative phosphorylation.

This leads to:

• Cellular necrosis

• Lactic acidosis

• Capillary leak

• Hepatic injury

• Shock

• Multi-organ dysfunction

The gastrointestinal tract and liver are particularly vulnerable.

The 5 Clinical Stages of Iron Poisoning

Understanding the timeline is one of the most important examination points.

Stage	Timing	Clinical Features
Stage 1	0–6 hours	Vomiting, abdominal pain, diarrhoea, GI bleeding
Stage 2	6–24 hours	Apparent recovery (“latent phase”)
Stage 3	12–48 hours	Shock, metabolic acidosis, seizures, coma
Stage 4	2–5 days	Hepatic failure
Stage 5	Weeks later	Gastric scarring or pyloric stenosis

High-yield exam point

A temporary improvement in symptoms does not indicate recovery. Patients may deteriorate rapidly during Stage 3.

Recognising Severe Iron Toxicity

MRCP Part 1 questions frequently ask which features indicate severe poisoning and require aggressive management.

Features suggesting severe toxicity

1. Metabolic acidosis

2. Persistent vomiting

3. Hypotension or shock

4. Altered mental state

5. Gastrointestinal bleeding

6. Serum iron >500 micrograms/dL

7. Hepatic dysfunction

8. Seizures

9. Significant tablet burden on abdominal X-ray

10. Rising lactate

Systemic symptoms are more important than the serum iron concentration alone.

Deferoxamine: Mechanism and Indications

Deferoxamine is the antidote used in severe iron poisoning. It chelates free iron to form ferrioxamine, which is then excreted by the kidneys.

Classically, urine may become “vin rosé” coloured, although this finding is not always present.

High-Yield Indications for Deferoxamine

Indication	Clinical Importance
Shock or hypotension	Indicates severe systemic toxicity
Metabolic acidosis	Suggests mitochondrial failure
Altered consciousness	CNS involvement
Serum iron >500 micrograms/dL	Associated with major toxicity
Persistent severe GI symptoms	Ongoing toxic absorption
Worsening clinical status	Treatment is guided clinically
Significant radiopaque tablets with symptoms	Large ingestion burden

Important MRCP nuance

Deferoxamine should be initiated based on clinical severity, not solely on the iron concentration.

Investigations in Iron Overdose

Blood tests

Candidates should know the core investigations:

• Serum iron concentration

• Arterial or venous blood gas

• Serum lactate

• Liver function tests

• Urea and electrolytes

• Coagulation profile

• Glucose

Acid–base findings

A high anion gap metabolic acidosis is common in severe poisoning.

Imaging

Abdominal X-ray

Iron tablets are classically radiopaque and may be visible on plain abdominal radiography.

This is a favourite exam detail because many medications are not visible on X-ray.

Management Principles

Management questions often ask for the “next best step”.

Initial management priorities

1. ABCDE assessment

2. Intravenous access

3. Fluid resuscitation

4. Blood gas analysis

5. Serum iron measurement

6. Toxicology consultation

7. Whole bowel irrigation if appropriate

8. Intravenous deferoxamine when indicated

Whole Bowel Irrigation

Whole bowel irrigation may be considered when:

• A large number of tablets are visible on imaging

• Significant ingestion is suspected

• Presentation is early

Polyethylene glycol solution is commonly used.

Activated Charcoal Does NOT Work

This is one of the most frequently tested toxicology traps in MRCP Part 1.

Activated charcoal poorly binds iron and is therefore ineffective in significant iron poisoning.

Candidates should avoid selecting activated charcoal in severe iron overdose scenarios unless another co-ingestant is involved.

Complications of Severe Iron Poisoning

Early complications

• Shock

• Seizures

• Metabolic acidosis

• ARDS

• Coagulopathy

Delayed complications

• Hepatic necrosis

• Gastric outlet obstruction

• Pyloric stenosis

• Gastrointestinal scarring

Practical Mini-Case

A 4-year-old boy presents 10 hours after ingesting an unknown quantity of iron tablets belonging to his mother. He initially developed profuse vomiting and abdominal pain but now appears calmer. Blood gas demonstrates metabolic acidosis, and serum iron concentration is 650 micrograms/dL.

What is the most appropriate next step?

A. Activated charcoalB. Observation onlyC. Intravenous deferoxamineD. Oral sodium bicarbonateE. Naloxone infusion

Answer: C. Intravenous deferoxamine

Explanation

This child has severe iron poisoning due to:

• Metabolic acidosis

• Very high serum iron level

• Significant gastrointestinal symptoms

• Risk of progression to systemic collapse

The temporary improvement represents the latent phase and should not reassure clinicians.

Activated charcoal is ineffective because it does not bind iron adequately.

The 5 Most Common MRCP Traps

1. Mistaking the latent phase for recovery

Patients may appear improved before rapid deterioration.

2. Using activated charcoal

Activated charcoal is ineffective in iron poisoning.

3. Ignoring metabolic acidosis

Acidosis strongly suggests systemic toxicity.

4. Treating based only on serum iron level

Clinical severity remains the key determinant.

5. Forgetting that iron tablets are radiopaque

Abdominal X-ray findings are commonly tested.

Practical MRCP Study Checklist

Before the exam, ensure you can confidently recall:

• The 5 stages of iron poisoning

• Deferoxamine indications

• Serum iron thresholds

• Features of systemic toxicity

• Why activated charcoal is ineffective

• Radiographic appearance of iron tablets

• Causes of metabolic acidosis

• Delayed hepatic complications

• Whole bowel irrigation indications

• Classic examination traps

For further revision, practise timed toxicology questions in the <a href=https://www.crackmedicine.com/qbank QBank</a> and assess retention using the <a href=https://www.crackmedicine.com/mock-tests mock tests</a>.

You can also consolidate acute medicine topics using the <a href=https://www.crackmedicine.com/lectures lecture library</a>.

Key Exam Pearls

• Iron overdose classically causes a high anion gap metabolic acidosis.

• Apparent clinical improvement may precede severe deterioration.

• Deferoxamine is indicated in systemic toxicity.

• Activated charcoal does not bind iron effectively.

• Iron tablets are radiopaque on abdominal X-ray.

• Hepatic failure may occur several days after ingestion.

FAQs

What serum iron level suggests severe toxicity?

A serum iron concentration above 500 micrograms/dL is associated with severe poisoning, especially when accompanied by systemic symptoms such as acidosis or shock.

Why is activated charcoal ineffective in iron overdose?

Activated charcoal does not significantly bind iron and therefore provides little benefit in substantial iron ingestion.

What colour urine may occur with deferoxamine therapy?

Patients treated with deferoxamine may develop “vin rosé” coloured urine due to ferrioxamine excretion.

What is the latent phase in iron poisoning?

The latent phase occurs approximately 6–24 hours after ingestion, when symptoms temporarily improve before systemic toxicity develops.

Why are children particularly vulnerable to iron toxicity?

Children may accidentally ingest large quantities of iron-containing tablets, particularly prenatal supplements, resulting in severe toxicity due to their lower body mass.

Ready to start?

Strengthen your preparation with structured revision via the MRCP Part 1 overview. Practise actively using the Free MRCP MCQs and simulate exam conditions with a Start a mock test.

For deeper understanding, combine this guide with lecture-based revision at:https://www.crackmedicine.com/lectures/

Sources

1. MRCP(UK) Examination Blueprint

2. TOXBASE Clinical Toxicology Guidance

3. British National Formulary (BNF)

4. Oxford Handbook of Clinical Medicine

5. Kumar and Clark’s Clinical Medicine

6. Royal College of Physicians Educational Resources

7. American Academy of Clinical Toxicology Guidance on Iron Poisoning